Levothyroxine sodium pentahydrate tablets–formulation considerations

N Kaur, R Suryanarayanan - Journal of Pharmaceutical Sciences, 2021 - Elsevier
Even though levothyroxine sodium pentahydrate tablets have been in the market since
1955, there continue to be recalls due to sub potency. We have comprehensively reviewed …

Design and development of an electroanalytical sensor based on molecularly imprinted polyaniline for the detection of thyroxine

D Singh, S Roy, N Mahindroo, A Mathur - Journal of Applied …, 2024 - Springer
Hypothyroidism and hyperthyroidism are one of the most frequently observed endocrine
disorders in the world. Failure to undergo timely diagnosis and treatment often results in life …

Electrochemical quantification of levothyroxine at disposable screen-printed electrodes

M David, A Şerban, TA Enache, M Florescu - Journal of Electroanalytical …, 2022 - Elsevier
The concentration of thyroxine hormone is linked to a large variety of medical conditions,
where the best therapy is hormone substitution, through administration of levothyroxine …

Direct analysis in real time–high resolution mass spectrometry as a valuable tool for the pharmaceutical drug development

J Srbek, B Klejdus, M Douša, J Břicháč, P Stasiak… - Talanta, 2014 - Elsevier
In this study, direct analysis in real time-mass spectrometry (DART-MS) was assessed for the
analysis of various pharmaceutical formulations with intention to summarize possible …

[HTML][HTML] Advancing drug safety and mitigating health concerns: High-resolution mass spectrometry in the levothyroxine case study

H Chmelařová, MC Catapano, JC Garrigues… - Journal of …, 2024 - Elsevier
Levothyroxine is a drug with a narrow therapeutic index. Changing the drug formulation
composition or switching between pharmaceutical brands can alter the bioavailability, which …

Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and …

M Ruggenthaler, J Grass, W Schuh, CG Huber… - … of pharmaceutical and …, 2017 - Elsevier
The structural elucidation of unknown pharmaceutical impurities plays an important role in
the quality control of newly developed and well-established active pharmaceutical …

Identification and quantification of electrochemically generated metabolites of thyroxine by means of liquid chromatography/electrospray-mass spectrometry and …

CK Mak, CA Wehe, M Sperling, U Karst - Journal of Chromatography A, 2015 - Elsevier
Thyroxine (T 4) is one of the major thyroid hormones, which regulates cellular metabolism,
central nervous system development, body temperature, reproduction and growth. The …

Impurity profiling of liothyronine sodium by means of reversed phase HPLC, high resolution mass spectrometry, on-line H/D exchange and UV/Vis absorption

M Ruggenthaler, J Grass, W Schuh, CG Huber… - … of Pharmaceutical and …, 2017 - Elsevier
For the first time, a comprehensive investigation of the impurity profile of the synthetic thyroid
API (active pharmaceutical ingredient) liothyronine sodium (LT 3 Na) was performed by …

Ultrahigh-performance liquid chromatography-ultraviolet absorbance detection-high-resolution-mass spectrometry combined with automated data processing for …

V Neu, C Bielow, K Reinert, CG Huber - Journal of chromatography A, 2014 - Elsevier
Levothyroxine as active pharmaceutical ingredient of formulations used for the treatment of
hypothyroidism is distributed worldwide and taken by millions of people. An important issue …

Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Amphiphilic Copolymers for Long-Acting Injectables: Synthesis, Non-Acylating Performance and In Vivo …

S Curia, F Ng, ME Cagnon, V Nicoulin… - Molecules, 2021 - mdpi.com
This article presents the evaluation of diblock and triblock poly (ethylene glycol)-b-poly (1, 3-
trimethylene carbonate) amphiphilic copolymers (PEG-PTMCs) as excipients for the …